1. ICD Patients: What Is the Efficacy of Early Activation of Atrial ATP Therapies in Atrial Fibrillation Termination?
- Author
-
M. Santini, P. A. Ravazzi, G. Altamura, S. Favale, G. Biancalana, and P. L. Padeletti
- Subjects
medicine.medical_specialty ,business.industry ,Atrial fibrillation ,medicine.disease ,Internal medicine ,cardiovascular system ,medicine ,Cardiology ,In patient ,cardiovascular diseases ,Implant ,Early activation ,medicine.symptom ,business ,Atrial tachycardia - Abstract
Atrial fibrillation (AF)/atrial tachycardia (AT) is one of the most common arrhythmias. It has been reported that a relevant percentage of patients implanted with implantable cardioverter defibrillators (ICDs) have atrial tachyarrhythmias at the time of implant [1]. One of the most interesting results of the recently available atrial-ventricular dual-chamber ICD clinical investigations is the significantly high success rate of automatic atrial anti-tachy-pacing (ATP) therapies in AF/AT termination: atrial bursts, ramps and high frequency bursts (50 Hz bursts) successfully terminated 68% of the device-detected atrial episodes [2–4] in patients with an indication for ventricular ICD. In spite of the considerably high AF/AT termination rate, no significant reduction was observed in terms of AF/AT burden or mean duration of AF/AT episodes. A possible explanation of these surprising data may relate to no limit being imposed on the ATP intervention delay from the episode onset.
- Published
- 2002
- Full Text
- View/download PDF